Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
07/2007
07/25/2007EP1809633A1 Constrained compounds as cgrp-receptor antagonists
07/25/2007EP1809632A2 Pyrazolo[4,3-d]pyrimidine derivatives useful as pde-5 inhibitors
07/25/2007EP1143933B1 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
07/19/2007WO2007080837A1 Process for production of substituted benzene
07/19/2007WO2007080325A1 Fgf-receptor agonist dimeric compounds
07/19/2007WO2007080191A1 6-phenyl-1h-imidazo[4, 5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors
07/19/2007US20070167481 Imidazonaphthyridines
07/19/2007US20070167468 Substituted bicyclic 8-pyrr0lidinoxanthines, methods for their production, pharmaceutical formulations and their use
07/19/2007US20070167428 Thienopyrroles as antagonists of gnrh
07/19/2007CA2635982A1 6-phenyl-1h-imidazo[4, 5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors
07/19/2007CA2626641A1 Compounds
07/18/2007CN1326872C Method for preparing echinocandin derivatives
07/18/2007CN1326842C Electrode-active material and electrodes made by using the same, and cells equipped with the electrodes
07/17/2007US7244724 Pyrrolobenzodiazepines
07/17/2007US7244723 Kinesin spindle protein (KSP) inhibitors, e.g., 3-benzyl-2-(1-{(4-bromobenzyl)[2-(dimethylamino)ethyl]amino}propyl)furo[2,3-d]pyrimidin-4(3H)-one; antiproliferative and -carcinogenic agents; side effects reduction; cancers of the brain, genitourinary tract, lymphatic system, stomach, larynx and lung
07/17/2007CA2395558C Intermediates for 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
07/12/2007US20070161795 Process for isolation of ergot alkaloids from ergot
07/11/2007EP1805187A1 Inhibitors of hepatitis c virus protease, and compositions and treatments using the same
07/11/2007EP1805186A2 Radicals and their use as paramagnetic agents in a dynamic nuclear polarisation process
07/11/2007EP1497287A4 Quinolinone derivatives
07/11/2007EP1248784B1 Condensed azepines as vasopressin agonists
07/11/2007CN1995040A 4-methyl-7-oxy-1-azabicyclo [3.2.0] hepta-2-olefin-2-carboxylic acid derivative preparation method
07/11/2007CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
07/10/2007CA2549561C 36- derivatives of rifamycins
07/10/2007CA2199401C Pyrimido[5,4-d]pyrimidines, medicaments comprising these compounds, their use and processes for their preparation
07/05/2007WO2007076127A2 Condensed imidazoles or pyrazoles and their use as transforming growth factor modulators
07/05/2007WO2007076086A2 Tricyclic spiro compounds useful as transforming growth factor modulators
07/05/2007WO2007075567A1 Triazolopyridazines as tyrosine kinase modulators
07/05/2007US20070155749 Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics
07/05/2007US20070155704 t-Butyl 1-[9-[1-(tert-butoxycarbonyl)cyclopropyl]-5-oxononyl]-1-cyclopropanecarboxylate; Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, impotence
07/05/2007CA2634721A1 Triazolopyridazines as tyrosine kinase modulators
07/04/2007EP1802637A1 Cgrp receptor antagonists
07/04/2007CN1993361A Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
07/04/2007CN1324025C Tropane derivatives as CCR5 modulators
07/03/2007US7238802 Intermediates for synthesis of vinblastines, process for preparation of the intermediates and process for synthesis on vinblastines
07/03/2007US7238704 For use as inhibitors of cellular mitosis and proliferation
07/03/2007US7238694 Rifamycin imino derivatives effective against drug-resistant microbes
07/03/2007US7238690 Substituted heterocycle fused gamma-carbolines
07/03/2007US7238461 contains a dye having at least two chromophores bonded to each other without any conjugated bond intervening between those chromophores; having a complex refractive index great in real part n and almost equal or small in imaginary part k
06/2007
06/28/2007WO2007072158A2 Pyrimidine derivatives for the treatment of abnormal cell growth
06/28/2007WO2007071648A1 Crystalline form of vinflunine ditartrate
06/28/2007WO2007071393A2 Sulphonamidoaniline derivatives being janus kinases inhibitors
06/28/2007WO2007053353A3 Pyrrolo[2,3-f] and [3,2-f]isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands
06/28/2007US20070149598 M3 muscarinic acetylcholine receptor antagonists
06/28/2007US20070149503 Anti-migraine spirocycles
06/28/2007US20070149502 Spirocyclic anti-migraine compounds
06/28/2007US20070148093 Non-terminal method of identifying anti-migraine compounds
06/28/2007US20070145361 Organic semiconductor material and organic electronic device
06/28/2007CA2633769A1 Crystalline form of vinflunine ditartrate
06/28/2007CA2631721A1 Sulphonamidoaniline derivatives being janus kinases inhibitors
06/27/2007EP1799691A1 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
06/27/2007CN1988956A Process for the photoactivation and use of a catalyst by an inverted two-stage procedure
06/26/2007US7235663 E.g., 2,6-Diethyl-4,4-dimethoxy-2,3,6-trimethyl-1-(1-(4-oxir-anylmethoxy-phenyl) -ethoxy)-piperidine or 7,9-Diethyl-2,6, 7,9-tetramethyl-8-(1-(4-oxiranylmethoxy-phenyl)-ethoxy)-1,4-dioxa-8-aza -spiro(4.5)decane; anionic polymerization
06/26/2007US7235656 Anxiolytic agents with reduced sedative and ataxic effects
06/26/2007US7235564 11'-substituted; potent inhibitors of cellular mitosis and proliferation
06/26/2007US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout
06/26/2007US7235538 Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV
06/21/2007US20070142370 Azabicyclooctan-3-one derivatives and use thereof
06/20/2007EP1797102A1 Composition comprising triarylmethyl radical, useful in mri diagnostics
06/20/2007CN1982308A Substituted pyrazoles
06/20/2007CN1321641C Method for treating allergies using substituted pyrazoles
06/19/2007US7232841 N-{4-[2-(1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl)-ethyl]-cyclohexyl}-2-[2-({4-[2-(1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl)-ethyl]-cyclohexylcarbamoyl}-methyl)-phenyl]-acetamide; treating COPD
06/19/2007US7232832 Antibacterial agents
06/19/2007US7232827 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives
06/19/2007US7232823 such as 1-[2-(2-chloro-phenyl)-3-(4-fluoro-phenyl)-2H-pyrazolo[3,4-d]pyridazin-7-yl]-4-isopropylamino-piperidine-4-carboxylic acid amide; for treatment of eating disorders and psychological disorders
06/14/2007US20070135458 6-Substituted pyrido-pyrimidines
06/14/2007US20070135444 Treatment of neuroblastoma
06/14/2007US20070135422 Nitrogen-containing bicycle heterocycles for use as antibacterials
06/14/2007US20070135402 Azetidine ring compounds and drugs comprising the same
06/14/2007US20070134729 Novel antibacterial agents
06/13/2007EP1326611B1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
06/13/2007CN1980938A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
06/12/2007US7230021 Therapy for immunology sensitive disease; marine animal extract
06/07/2007WO2007064797A2 Inhibitors of c-met and uses thereof
06/07/2007WO2007044426A3 Pyrazolopyrimidines as protein kinase inhibitors
06/07/2007WO2006051413A8 Azabenoxazoles for the treatment of cns disorders
06/07/2007CA2630884A1 Inhibitors of c-met and uses thereof
06/06/2007EP1792905A1 Product containing at least one phosphatase CDC25 inhibitor combined with at least one other anticancer agent
06/06/2007CN1976930A 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones useful as anti-infective pharmaceutical agents
06/05/2007USRE39680 Sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists
06/05/2007USRE39679 Substituted heterocycle fused gamma-carbolines
06/05/2007US7227020 protein kinase inhibitors; asthma, psoriasis, antiinflammatory agents; inflammatory bowel disorders
06/05/2007US7226938 Heterocyclic compounds
05/2007
05/31/2007WO2007060886A1 Therapeutic agent for neurodegenerative disease
05/31/2007WO2007059949A1 Two novel salts of the n, n' -bis [9- (3,4-dihydroxy-5- (2-ethyl-2h-tetrazol-5-yl) tetrahydrofuran-2-yl) -2- (2- (1-methyl-1h-imidazol-4-yl) ethylamino) -9h-purin-6-yl] cyclohexyl-1,4-diamine adenosine a2a agonist as anti-inflammatory agents
05/31/2007WO2007037518A9 Mutilin derivative and pharmaceutical composition containing the same
05/31/2007US20070123705 Alkylation; serotonin receptor antagonists; depression, obsessive compulsive disorders, panic disorder, generalized anxiety disorder, social anxiety, sexual dysfunction, bulimia, obesity, addictive disorder
05/31/2007US20070122166 Image forming apparatus and image forming system
05/31/2007CA2630271A1 Fused bicyclic mtor inhibitors
05/30/2007EP1789047A2 Treatment of diseases using nalmefene and its analgos
05/30/2007EP1117667B1 BENZOTHIENO[3,2-c]PYRIDINES AS ALPHA2 ANTAGONISTS
05/30/2007CN1972940A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists
05/29/2007US7223738 Inhibitors of Akt activity
05/24/2007WO2007057775A1 Spiropiperidine derivatives
05/24/2007US20070117799 Oxabispidine compounds useful in the treatment of cardiac arrhythmias
05/24/2007US20070116981 Single-layer organic el device
05/23/2007EP1787992A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
05/23/2007CN1968951A Novel 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydroisoindol-l-one/5,6-dihydro-furo[2,3-c]pyrrol-4one derivatives ligands for alpha 7 nicotinic acetylcholine receptor
05/23/2007CN1968947A Heterocyclic condensed compounds useful as antidiuretic agents
05/22/2007US7220862 Calcitonin gene related peptide receptor antagonists
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 111